View Future GrowthThis company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsPowerUp Acquisition 과거 순이익 실적과거 기준 점검 0/6PowerUp Acquisition의 수입은 연평균 -20.7%의 비율로 감소해 온 반면, Capital Markets 산업의 수입은 연간 6.3% 증가했습니다.핵심 정보-20.74%순이익 성장률-267.15%주당순이익(EPS) 성장률Capital Markets 산업 성장률10.26%매출 성장률n/a자기자본이익률n/a순이익률n/a최근 순이익 업데이트30 Sep 2024최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Aug 16PowerUp Acquisition Corp. announced delayed 10-Q filingOn 08/15/2024, PowerUp Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 01Aspire BioPharma, Inc. signed a non-binding letter of intent to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction.Aspire BioPharma, Inc. signed a non-binding letter of intent to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction on July 31, 2024. The transaction is subject to various contingencies and conditions, including the Aspire Biopharma's requisite investor consents, third party consents and regulatory review, including from the Securities and Exchange Commission and a national securities exchange. Dykema Gossett, PLLC serves as legal counsel to PowerUp Acquisition Corp. Sichenzia Ross Ference Carmel LLP serves as legal counsel to Aspire BioPharma, Inc.공시 • May 17PowerUp Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, PowerUp Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.New Risk • Mar 13New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-US$322k). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$99.4m market cap).Board Change • Dec 31High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Mayur Doshi is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Dec 29Visiox Pharmaceuticals, Inc. executed definitive agreement to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction for $0.3 million.Visiox Pharmaceuticals, Inc. executed definitive agreement to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction for $0.3 million on December 26, 2023. The merger would result in Visiox becoming a publicly traded company on the Nasdaq Capital Market. Upon closing, the combined company will be named Visiox Holdings, Inc. with its common stock and warrants expected to be listed on Nasdaq under the ticker symbols VSXP and VSXPW, respectively. Upon the closing of the Transaction, Visiox will continue to be led by current Chief Executive Officer, Ryan Bleeks. The Merger Agreement contains customary conditions to Closing, including the following mutual conditions of the parties (unless waived): (i) approval of the shareholders of PowerUp and Visiox of the Transaction and the other matters requiring shareholder approval; (ii) approvals of any required governmental authorities and completion of any antitrust expiration periods; (iii) receipt of specified third party consents; (iv) no law or order preventing the Transaction; (v) the Registration Statement having been declared effective by the SEC; (vi) the satisfaction of the $5,000,001 minimum net tangible asset test by PowerUp; (vii) approval from Nasdaq for the listing of the shares of PowerUp’s common stock to be issued in connection with the Transaction; and (viii) reconstitution of the Post-Closing Board as contemplated under the Merger Agreement. Kate Bechen of Dykema Gossett PLLC serves as legal counsel to PowerUp Acquisition Corp. and David Mannheim of Nelson Mullins Riley & Scarborough LLP serves as legal counsel to Visiox Pharmaceuticals, Inc.New Risk • Nov 10New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$63k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$63k). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$98.1m market cap).New Risk • Nov 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (9.4% average weekly change).공시 • Aug 25+ 3 more updatesPowerup Acquisition Corp. Announces Board ChangesPowerUp Acquisition Corp. announced that on the Effective Date, in connection with the Purchase Agreement, (i) Bruce Hack, Jack Tretton, Peter Blacklow, Julie Uhrman, and Kyle Campbell (the Resigning Directors") tendered their resignations as members of the board of directors of the Company (the Board"), (ii) Jack Tretton, Michael Olson, and Gabriel Schillinger resigned as officers of the Company, (iii) Surendra Ajjarapu, Michael L. Peterson, Donald G. Fell, Mayur Doshi, and Avinash Wadhwani were appointed as members of the Board (each, a New Director"), (iv) Surendra Ajjarapu was appointed Chairman of the Board, and (v) Surendra Ajjarapu and Howard Doss were appointed as the Company's Chief Executive Officer and Chief Financial Officer, respectively (each, a New Officer"). Suren Ajjarapu (age: 53) has served as Chairman of the Board, Chief Executive Officer and Secretary of TrXADE HEALTH, INC and its predecessor company since July 2010. He is also currently a director of Oceantech Acquisition I Corp., traded on Nasdaq under the symbol OTECU", serves as Chairman of the board of directors of Kernel Group Holdings Inc. and Semper Paratus Acquisition Corporation, a special purpose acquisition company. Beginning in 2021, Mr. Ajjarapu served as Chief Executive Officer and Chairman of Aesther Healthcare Acquisition Corp., a special purpose acquisition company that consummated its initial business combination in February 2023. Mr. Ajjarapu is currently serving as a director of the merged company, Ocean Biomedical Inc. Since March 2018, Mr. Ajjarapu has served as Executive Chairman of the Board of Kano Energy Corp., a company involved in the development of renewable natural gas sites in the United States. Mr. Ajjarapu was a Founder and served as Chief Executive Officer and Chairman of the Board of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest of the United States, from March 2009 to December 2012. Mr. Ajjarapu was also a Founder, President and Director of Aemetis Inc. and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis Inc., from January 2006 to March 2009. Mr. Ajjarapu was Co-Founder, Chief Operations Officer, and Director of Global Information Technology Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India. Mr. Ajjarapu graduated from South Dakota State University with a M.S. in Environmental Engineering, and from the University of South Florida with an M.B.A., specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University. Michael Peterson (age: 61) commenced serving as President, Chief Executive Officer and as a member of the Board of Directors of Lafayette Energy Corp. in April 2022. Beginning in September 2021, Mr. Peterson served as a member of the Board of Directors, Audit Committee (Chair), Compensation Committee and Nominating and Corporate Governance Committee of Aesther Healthcare Acquisition Corp. Mr. Peterson is currently serving as a director of the merged company, Ocean Biomedical Inc. In addition, Mr. Peterson commenced serving as an independent director of Oceantech Acquisition I Corp., in March 2023, began serving as an independent director of KRNL in December 2022 and as an independent director of Semper Paratus Acquisition Corporation in June 2023. Mr. Peterson has served as the president of Nevo Motors Inc. since December 2020, which was established to commercialize a range extender generator technology for the heavy-duty electric vehicle market but is currently non-operational. Since May 2022, Mr. Peterson has served as a member of the Board of Directors and as the Chairperson of the Audit Committee of Trio Petroleum Corp., an oil and gas exploration and development company which is in the process of going public. Since February 2021, Mr. Peterson has served on the board of directors and as the Chairman of the Audit Committee of Indonesia Energy Corporation Limited (NYSE American: INDO). Mr. Peterson previously served as the president of the Taipei Taiwan Mission of The Church of Jesus Christ of Latter-day Saints, in Taipei, Taiwan from June 2018 to June 2021. Mr. Peterson served as an independent member of the Board of Directors of TRxADE HEALTH, INC from August 2016 to May 2021. Mr. Peterson served as the Chief Executive Officer of PEDEVCO Corp.Mr. Peterson served as Chief Financial Officer of PEDEVCO between July 2012 and May 2016, and as Executive Vice President of Pacific Energy Development (PEDEVCO's predecessor) from July 2012 to October 2014, and as PEDEVCO's President from October 2014 to May 2018. Mr. Peterson joined Pacific Energy Development as its Executive Vice President in September 2011, assumed the additional office of Chief Financial Officer in June 2012, and served as a member of its board of directors from July 2012 to September 2013. Mr. Peterson formerly served as Interim President and CEO (from June 2009 to December 2011) and as director (from May 2008 to December 2011) of Pacific Energy Development, as a director (from May 2006 to July 2012) of Aemetis Inc. and as Chairman and Chief Executive Officer of Nevo Energy Inc. From 2005 to 2006, Mr. Peterson served as a managing partner of American Institutional Partners, a venture investment fund based in Salt Lake City. From 2000 to 2004, he served as a First Vice President at Merrill Lynch, where he helped establish a new private client services division to work exclusively with high-net-worth investors. From September 1989 to January 2000, Mr. Peterson was employed by Goldman Sachs & Co. in a variety of positions and roles, including as a Vice President. Mr. Peterson received his MBA at the Marriott School of Management and a BS in statistics/computer science from Brigham Young University.공시 • May 20PowerUp Acquisition Corp. Appoints Kyle Campbell, as Class Iii Director, Effective May 16, 2022Effective May 16, 2022, the board of directors of PowerUp Acquisition Corp. appointed Kyle Campbell, as a Class III director of the Company. In connection with his appointment to the Board, Mr. Campbell has been appointed to the Audit Committee of the Board. Since May 2021, Mr. Campbell has served as a senior analyst at Greenhaven Road Capital.Seeking Alpha • Apr 22PowerUp Acquisition Purses Video Gaming And Metaverse TargetsPowerUp Acquisition went public recently, garnering approximately $288 million in an IPO. The SPAC seeks to merge with a target in the video gaming and related industries. While management's video gaming background is impressive, they lack a SPAC track record, so I'm on Hold for PWUP in the near term.매출 및 비용 세부 내역PowerUp Acquisition가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NasdaqGM:PWUP 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비30 Sep 240-42030 Jun 240-34031 Mar 240-14031 Dec 23041030 Sep 23071030 Jun 23081031 Mar 23061031 Dec 22031030 Sep 22011030 Jun 22000031 Mar 220000양질의 수익: PWUP 은(는) 현재 수익성이 없습니다.이익 마진 증가: PWUP는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 PWUP의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: 현재 수익성이 없어 지난 1년간 PWUP의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: PWUP은 수익성이 없어 지난 해 수익 성장률을 Capital Markets 업계(37.2%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: PWUP의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YDiversified-financials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/02/19 09:27종가2025/02/14 00:00수익2024/09/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스PowerUp Acquisition Corp.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Aug 16PowerUp Acquisition Corp. announced delayed 10-Q filingOn 08/15/2024, PowerUp Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 01Aspire BioPharma, Inc. signed a non-binding letter of intent to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction.Aspire BioPharma, Inc. signed a non-binding letter of intent to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction on July 31, 2024. The transaction is subject to various contingencies and conditions, including the Aspire Biopharma's requisite investor consents, third party consents and regulatory review, including from the Securities and Exchange Commission and a national securities exchange. Dykema Gossett, PLLC serves as legal counsel to PowerUp Acquisition Corp. Sichenzia Ross Ference Carmel LLP serves as legal counsel to Aspire BioPharma, Inc.
공시 • May 17PowerUp Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, PowerUp Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
New Risk • Mar 13New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-US$322k). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$99.4m market cap).
Board Change • Dec 31High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Mayur Doshi is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Dec 29Visiox Pharmaceuticals, Inc. executed definitive agreement to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction for $0.3 million.Visiox Pharmaceuticals, Inc. executed definitive agreement to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction for $0.3 million on December 26, 2023. The merger would result in Visiox becoming a publicly traded company on the Nasdaq Capital Market. Upon closing, the combined company will be named Visiox Holdings, Inc. with its common stock and warrants expected to be listed on Nasdaq under the ticker symbols VSXP and VSXPW, respectively. Upon the closing of the Transaction, Visiox will continue to be led by current Chief Executive Officer, Ryan Bleeks. The Merger Agreement contains customary conditions to Closing, including the following mutual conditions of the parties (unless waived): (i) approval of the shareholders of PowerUp and Visiox of the Transaction and the other matters requiring shareholder approval; (ii) approvals of any required governmental authorities and completion of any antitrust expiration periods; (iii) receipt of specified third party consents; (iv) no law or order preventing the Transaction; (v) the Registration Statement having been declared effective by the SEC; (vi) the satisfaction of the $5,000,001 minimum net tangible asset test by PowerUp; (vii) approval from Nasdaq for the listing of the shares of PowerUp’s common stock to be issued in connection with the Transaction; and (viii) reconstitution of the Post-Closing Board as contemplated under the Merger Agreement. Kate Bechen of Dykema Gossett PLLC serves as legal counsel to PowerUp Acquisition Corp. and David Mannheim of Nelson Mullins Riley & Scarborough LLP serves as legal counsel to Visiox Pharmaceuticals, Inc.
New Risk • Nov 10New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$63k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$63k). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$98.1m market cap).
New Risk • Nov 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (9.4% average weekly change).
공시 • Aug 25+ 3 more updatesPowerup Acquisition Corp. Announces Board ChangesPowerUp Acquisition Corp. announced that on the Effective Date, in connection with the Purchase Agreement, (i) Bruce Hack, Jack Tretton, Peter Blacklow, Julie Uhrman, and Kyle Campbell (the Resigning Directors") tendered their resignations as members of the board of directors of the Company (the Board"), (ii) Jack Tretton, Michael Olson, and Gabriel Schillinger resigned as officers of the Company, (iii) Surendra Ajjarapu, Michael L. Peterson, Donald G. Fell, Mayur Doshi, and Avinash Wadhwani were appointed as members of the Board (each, a New Director"), (iv) Surendra Ajjarapu was appointed Chairman of the Board, and (v) Surendra Ajjarapu and Howard Doss were appointed as the Company's Chief Executive Officer and Chief Financial Officer, respectively (each, a New Officer"). Suren Ajjarapu (age: 53) has served as Chairman of the Board, Chief Executive Officer and Secretary of TrXADE HEALTH, INC and its predecessor company since July 2010. He is also currently a director of Oceantech Acquisition I Corp., traded on Nasdaq under the symbol OTECU", serves as Chairman of the board of directors of Kernel Group Holdings Inc. and Semper Paratus Acquisition Corporation, a special purpose acquisition company. Beginning in 2021, Mr. Ajjarapu served as Chief Executive Officer and Chairman of Aesther Healthcare Acquisition Corp., a special purpose acquisition company that consummated its initial business combination in February 2023. Mr. Ajjarapu is currently serving as a director of the merged company, Ocean Biomedical Inc. Since March 2018, Mr. Ajjarapu has served as Executive Chairman of the Board of Kano Energy Corp., a company involved in the development of renewable natural gas sites in the United States. Mr. Ajjarapu was a Founder and served as Chief Executive Officer and Chairman of the Board of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest of the United States, from March 2009 to December 2012. Mr. Ajjarapu was also a Founder, President and Director of Aemetis Inc. and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis Inc., from January 2006 to March 2009. Mr. Ajjarapu was Co-Founder, Chief Operations Officer, and Director of Global Information Technology Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India. Mr. Ajjarapu graduated from South Dakota State University with a M.S. in Environmental Engineering, and from the University of South Florida with an M.B.A., specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University. Michael Peterson (age: 61) commenced serving as President, Chief Executive Officer and as a member of the Board of Directors of Lafayette Energy Corp. in April 2022. Beginning in September 2021, Mr. Peterson served as a member of the Board of Directors, Audit Committee (Chair), Compensation Committee and Nominating and Corporate Governance Committee of Aesther Healthcare Acquisition Corp. Mr. Peterson is currently serving as a director of the merged company, Ocean Biomedical Inc. In addition, Mr. Peterson commenced serving as an independent director of Oceantech Acquisition I Corp., in March 2023, began serving as an independent director of KRNL in December 2022 and as an independent director of Semper Paratus Acquisition Corporation in June 2023. Mr. Peterson has served as the president of Nevo Motors Inc. since December 2020, which was established to commercialize a range extender generator technology for the heavy-duty electric vehicle market but is currently non-operational. Since May 2022, Mr. Peterson has served as a member of the Board of Directors and as the Chairperson of the Audit Committee of Trio Petroleum Corp., an oil and gas exploration and development company which is in the process of going public. Since February 2021, Mr. Peterson has served on the board of directors and as the Chairman of the Audit Committee of Indonesia Energy Corporation Limited (NYSE American: INDO). Mr. Peterson previously served as the president of the Taipei Taiwan Mission of The Church of Jesus Christ of Latter-day Saints, in Taipei, Taiwan from June 2018 to June 2021. Mr. Peterson served as an independent member of the Board of Directors of TRxADE HEALTH, INC from August 2016 to May 2021. Mr. Peterson served as the Chief Executive Officer of PEDEVCO Corp.Mr. Peterson served as Chief Financial Officer of PEDEVCO between July 2012 and May 2016, and as Executive Vice President of Pacific Energy Development (PEDEVCO's predecessor) from July 2012 to October 2014, and as PEDEVCO's President from October 2014 to May 2018. Mr. Peterson joined Pacific Energy Development as its Executive Vice President in September 2011, assumed the additional office of Chief Financial Officer in June 2012, and served as a member of its board of directors from July 2012 to September 2013. Mr. Peterson formerly served as Interim President and CEO (from June 2009 to December 2011) and as director (from May 2008 to December 2011) of Pacific Energy Development, as a director (from May 2006 to July 2012) of Aemetis Inc. and as Chairman and Chief Executive Officer of Nevo Energy Inc. From 2005 to 2006, Mr. Peterson served as a managing partner of American Institutional Partners, a venture investment fund based in Salt Lake City. From 2000 to 2004, he served as a First Vice President at Merrill Lynch, where he helped establish a new private client services division to work exclusively with high-net-worth investors. From September 1989 to January 2000, Mr. Peterson was employed by Goldman Sachs & Co. in a variety of positions and roles, including as a Vice President. Mr. Peterson received his MBA at the Marriott School of Management and a BS in statistics/computer science from Brigham Young University.
공시 • May 20PowerUp Acquisition Corp. Appoints Kyle Campbell, as Class Iii Director, Effective May 16, 2022Effective May 16, 2022, the board of directors of PowerUp Acquisition Corp. appointed Kyle Campbell, as a Class III director of the Company. In connection with his appointment to the Board, Mr. Campbell has been appointed to the Audit Committee of the Board. Since May 2021, Mr. Campbell has served as a senior analyst at Greenhaven Road Capital.
Seeking Alpha • Apr 22PowerUp Acquisition Purses Video Gaming And Metaverse TargetsPowerUp Acquisition went public recently, garnering approximately $288 million in an IPO. The SPAC seeks to merge with a target in the video gaming and related industries. While management's video gaming background is impressive, they lack a SPAC track record, so I'm on Hold for PWUP in the near term.